GeneL.ColiceMD

Critical Care Medicine, Pleural Disease

Professor, Medicine, G Washington University School of Medicine & Hlth Sci

Dr. Colice is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Yale-New Haven Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1980 - 1982
New York University School of MedicineClass of 1976

PubMed

17 citations
Tezepelumab Pharmacokinetics, Safety, and Tolerability After Administration via Vial-and-syringe, Accessorized Prefilled Syringe, or Autoinjector: A Randomized Trial i...
Yanan Zheng, Lubna Abuqayyas, Ayman Megally, Rainard Fuhr, Kinga Sałapa
Clinical Therapeutics. 2021-01-01
359 citations
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.
Andrew Menzies-gow, Jonathan Corren, Arnaud Bourdin, Geoffrey Chupp, Elliot Israel
The New England Journal of Medicine. 2021-05-12
51 citations
Baseline type 2 biomarker levels and response to tezepelumab in severe asthma.
Jonathan Corren, Tuyet-Hang Pham, Esther Garcia Gil, Kinga Sałapa, Pin Ren
Allergy. 2022-06-01

Journal Articles

Tralokinumab Did Not Demonstrate Oral Corticosteroid-Sparing Effects in Severe Asthma
Gene Colice, MD, The European Respiratory Journal

Should Fibrinolytics Be Routinely Administered Intrapleurally for Complicated Parapneumonic Effusion?January 7th, 2014